Award recordCONTRACT

PFIZER INC

PIID VA52816F0890· VHA· 242-NETWORK CONTRACT OFFICE 02· 6505 · DRUGS AND BIOLOGICALS· FY2016· $10,346 net obligations· UEI MHBQULRMEEJ5· NY

Description

SOMAVERT 30MG/ML INJ PEGVISOMANT PROTEIN 30MG/VIL INJ

First action · last action
2016-03-30 · 2016-03-30
Transactions
1
First transaction's obligation
$10,346
Base + all options value (sum of deltas)
$10,346
Extent competed
FULL AND OPEN COMPETITION
Other than full & open authority
—
Set-aside
NO SET ASIDE USED.
Offers received
1
SDVOSB flag on record
No
Parent IDV
VA797P15A0001
NAICS
325412 · PHARMACEUTICAL PREPARATION MANUFACTURING

Modification chain · 1 transaction

Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.

$10,346$0Base award · 2016-03-30 · this action $10,346 · running total $10,346
  • Base2016-03-30+$10,346= $10,346
TransactionAction dateThis action (delta)Running totalDescription on this transaction
Base2016-03-30+$10,346$10,346SOMAVERT 30MG/ML INJ PEGVISOMANT PROTEIN 30MG/VIL INJ

Related awards · 11

Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.

Other VA awards to the same recipient (UEI MHBQULRMEEJ5)

AwardOffice · PSC / listingNet obligationsFY
36E79725D0032NAC PHARMACEUTICALS (36E797) · 6505 · DRUGS AND BIOLOGICALS$0FY2025
36E79725D0030NAC PHARMACEUTICALS (36E797) · 6505 · DRUGS AND BIOLOGICALS$0FY2025
36C77024P0393NATIONAL CMOP OFFICE (36C770) · 6505 · DRUGS AND BIOLOGICALS$243,101FY2024
36F79724D0130NAC FEDERAL SUPPLY SCHEDULE (36F797) · 6505 · DRUGS AND BIOLOGICALS$0FY2024
36C25024F0047250-NETWORK CONTRACT OFFICE 10 (36C250) · 6505 · DRUGS AND BIOLOGICALS$215,205FY2024
36E79723A0023NAC PHARMACEUTICALS (36E797) · 6505 · DRUGS AND BIOLOGICALS$0FY2023

Other recipients under 6505 from 242-NETWORK CONTRACT OFFICE 02 (most recent first)

AwardRecipientOfficeNet obligationsFY
VA52816F0808BAYER HEALTHCARE PHARMACEUTICALS INC242-NETWORK CONTRACT OFFICE 02$16,180FY2016
VA52816F0388CSL BEHRING L.L.C.242-NETWORK CONTRACT OFFICE 02$1,097FY2016
VA24016E0142MCKESSON CORPORATION242-NETWORK CONTRACT OFFICE 02$5,517,543FY2016
VA52816J0701CEPHEID242-NETWORK CONTRACT OFFICE 02$234,636FY2016
VA52816F0361BAYER HEALTHCARE PHARMACEUTICALS INC242-NETWORK CONTRACT OFFICE 02$5,311FY2016

Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_VA52816F0890_3600_VA797P15A0001_3600 · retrieved 2026-09-26.